Back to search
Irritable Bowel Syndrome Constipation Predominant
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Irritable Bowel Syndrome Constipation Predominant trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Irritable Bowel Syndrome Constipation Predominant trials you may qualify forIrritable Bowel Syndrome (IBS), characterized by the Rome IV criteria, is a functional bowel disorder combining abdominal pain with changes in bowel habits and/…
This is a double-blind, randomized (group assignment by chance), placebo-controlled, multicenter trial which will be conducted over a 13.5-months period The mai…
The study will aim to evaluate the effectiveness of the use of a food supplement, based on a green tea extract (Camellia sinensis (L.) Kuntze - folium) and a po…
This randomized, double-blind, placebo-controlled trial will evaluate whether a 14-day course of rifaximin improves bloating in adult patients with Rome IV func…
The primary objective is to compare the effectiveness of the experimental Intermittent Colonic Exoperistalsis (ICE) treatment with MOWOOT, with the active contr…
Goal of this study is to evaluate the efficacy and safety of two different doses of Linaclotide in improving bowel function and patient-reported outcomes among…